Hans Moebius, Chief Medical Officer at Athira Pharma, Inc. (ATHA), bought 5,000 shares at $3.29 ($16K) on 2022-11-15, disclosed to the SEC on 2022-11-17.
Open-market purchase of $16k ATHA by Chief Medical Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.